NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Aker Biomarine AS (OL: AKBM)

 
AKBM Technical Analysis
2
As on 1st Apr 2025 AKBM STOCK Price closed @ 56.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 64.34 & Strong Buy for SHORT-TERM with Stoploss of 41.72 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

AKBMSTOCK Price

Open 56.50 Change Price %
High 59.00 1 Day -0.60 -1.06
Low 55.60 1 Week -1.80 -3.11
Close 56.00 1 Month -12.00 -17.65
Volume 31086 1 Year 17.05 43.77
52 Week High 107.00 | 52 Week Low 37.00
 
OL Norway Most Active Stocks
EAM 0.75 4.17%
BORR 40.56 0.00%
AOW 2.00 -5.21%
NAS 12.67 5.76%
IDEX 0.04 -20.00%
NEL 2.42 1.26%
NHY 59.96 -0.60%
NODL 0.23 -11.54%
ACH 3.90 2.36%
SDRL 404.80 0.00%
 
OL Norway Top Gainers Stocks
INSR 0.18 12.50%
INDCT 3.56 11.95%
HUDL 1.25 11.61%
KOMP 5.22 9.66%
DSRT 6.60 7.84%
BGBIO 1.82 7.06%
HYARD 2.94 6.91%
SOHO 35.00 6.06%
SOHO 35.00 6.06%
SOHO 35.00 6.06%
 
OL Norway Top Losers Stocks
AWDR 1.24 -94.54%
IDEX 0.04 -20.00%
IDEX 0.04 -20.00%
ABS 5.00 -18.03%
ABS 5.00 -18.03%
ABS 5.00 -18.03%
ABS 5.00 -18.03%
ABS 5.00 -18.03%
ABT 5.00 -13.49%
ABT 5.00 -13.49%
 
 
AKBM
Daily Charts
AKBM
Intraday Charts
Whats New @
Bazaartrend
AKBM
Free Analysis
 
AKBM Important Levels Intraday
RESISTANCE62.55
RESISTANCE60.45
RESISTANCE59.15
RESISTANCE57.85
SUPPORT54.15
SUPPORT52.85
SUPPORT51.55
SUPPORT49.45
 
AKBM Forecast April 2025
4th UP Forecast77.68
3rd UP Forecast70.73
2nd UP Forecast66.43
1st UP Forecast62.13
1st DOWN Forecast49.87
2nd DOWN Forecast45.57
3rd DOWN Forecast41.27
4th DOWN Forecast34.32
 
AKBM Weekly Forecast
4th UP Forecast61.59
3rd UP Forecast59.80
2nd UP Forecast58.69
1st UP Forecast57.58
1st DOWN Forecast54.42
2nd DOWN Forecast53.31
3rd DOWN Forecast52.20
4th DOWN Forecast50.41
 
AKBM Forecast2025
4th UP Forecast197.83
3rd UP Forecast152.34
2nd UP Forecast124.23
1st UP Forecast96.11
1st DOWN Forecast15.89
2nd DOWN Forecast-12.23
3rd DOWN Forecast-40.34
4th DOWN Forecast-85.83
 
 
AKBM Other Details
Segment EQ
Market Capital 3936995072.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
AKBM Address
AKBM
 
AKBM Latest News
 
Your Comments and Response on Aker Biomarine AS
 
AKBM Business Profile
Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates in two segments, Ingredients and Brands. The company provides krill oil products, including omega-3s, phospholipids, choline, and astaxanthin under the Superba, Kori, NKO, and K·REAL brands. It also offers Qrill aqua nutrient-rich feed ingredients for aquaculture; and QRILL pet, a functional ingredient for pet food. The company also offers LYSOVETA, a delivery platform based on LPC-bound EPA and DHA from krill; and INVI, a hydrolyzed protein isolate for food and beverage applications. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles waste into products, such as shopping baskets and food trays. Aker BioMarine AS has an agreement with Medical Food Solutions Research to develop pharmaceutical therapies for brain and eye health based on Lysoveta. The company is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA. Address: Oksenøyveien 10, Lysaker, Norway, 1327
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service